KAREN PARMELY: Open Payments
NPI 1689133647 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 46 payments from 21 companies in 2025. Trend: 2023 $76 · 2024 $1,223 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $232 |
| Axsome Therapeutics, Inc. | 4 | $174 |
| SHIELD THERAPEUTICS INC | 2 | $132 |
| Abbott Laboratories | 1 | $120 |
| ABBVIE INC. | 4 | $95 |
| Ardelyx, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Lilly USA, LLC | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Almatica Pharma LLC | 2 | $49 |
Products named: Auvelity, AIRSUPRA, ACCRUFER, FREESTYLE LIBRE 3, IBSRELA, CAPLYTA, BREZTRI, LOREEV XR.
Industry payments across KS — which companies pay providers there.
